(Pyr16)-VIP (16-28) (human, bovine, porcine, rat)
CAS No. 134907-86-1
(Pyr16)-VIP (16-28) (human, bovine, porcine, rat)( ——— )
Catalog No. M40487 CAS No. 134907-86-1
(Pyr16)-VIP (16-28) (human, bovine, porcine, rat)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(Pyr16)-VIP (16-28) (human, bovine, porcine, rat)
-
NoteResearch use only, not for human use.
-
Brief Description(Pyr16)-VIP (16-28) (human, bovine, porcine, rat)
-
Description(Pyr16)-VIP (16-28) (human, bovine, porcine, rat)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number134907-86-1
-
Formula Weight1503.86
-
Molecular FormulaC68H1141N18O18S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
(D-2-Nal5,Cys6·11,Ty...
BIM 23042, a certain somatostatin (SS) octapeptide analogue, is a selective neuropeptide neuromedin B receptor (NMB-R, BB1) antagonist. BIM 23042 has 100-fold lower affinity for gastrin-releasing peptide (GRP) receptor (BB2). BIM 23042 inhibits Neuromedin?B?, ICI 216140 and DPDM-bombesin ethylamide-induced Ca2+ release.
-
Kaempferol-3-O-galac...
Kaempferol-3-O-galactoside has antioxidant, anti-inflammatory and antinociceptive activities.
-
neo-gambogic acid
Neogambogic acid an active ingredient in garcinia can inhibit the growth of some solid tumors and result in an anticancer effect it may be responsible for the inhibition of proliferation of human breast cancer cell line MCF-7 cells.
Cart
sales@molnova.com